Long-Acting Local Anaesthetic (Amide)
Pregnancy: Used in epidural analgesia in labour; consider benefit-risk
Levobupivacaine
Brand names: Chirocaine
Adult dose
Dose: Epidural: 10-20 mL of 0.125-0.5%. Nerve block: 0.25-0.75%, up to max dose. Intrathecal: 1.5-3.5 mL of 0.5%
Route: Epidural / Intrathecal / Peripheral nerve block / Local infiltration
Frequency: Single injection or continuous infusion
Max: 2.5 mg/kg (plain); up to 3.75 mg/kg (with adrenaline)
Pure S-enantiomer of bupivacaine — less cardiotoxic than racemic bupivacaine. Potency similar to bupivacaine. Can be used intrathecally unlike ropivacaine
Paediatric dose
Dose: 1.25-2.5 mg/kg (caudal/epidural) mg/kg
Route: Epidural / Caudal
Frequency: Single or continuous
Max: 2.5 mg/kg
Seek specialist paediatric anaesthesia input
Dose adjustments
Renal
No adjustment for single doses
Hepatic
Caution with prolonged infusions in hepatic impairment
Paediatric weight-based calculator
Seek specialist paediatric anaesthesia input
Clinical pearls
- S-enantiomer of bupivacaine: binds cardiac Na+ channels with lower affinity than racemic bupivacaine — significantly lower cardiotoxicity with equivalent analgesic potency
- Unlike ropivacaine, levobupivacaine can be used intrathecally (spinal) — gives more flexibility than ropivacaine which is not licensed for spinal use
- LAST treatment: 20% intralipid — 1.5 mL/kg bolus, 0.25 mL/kg/min infusion; lipid rescue equally applicable to all amide local anaesthetics
- Interchangeable with bupivacaine in most regional anaesthetic techniques at equal volumes and concentrations
- Preferred over racemic bupivacaine in some centres for its improved safety profile during prolonged epidural infusions
Contraindications
- IV administration (unless LAST treatment)
- Inflamed or infected injection site
Side effects
- LAST (less cardiotoxic than bupivacaine)
- Hypotension (sympathetic block)
- Urinary retention
- Motor block
Interactions
- Other local anaesthetics (additive toxicity)
- Adrenaline (extends duration)
Monitoring
- Cardiovascular monitoring
- Block level
- Signs of LAST
Reference: BNFc; BNF 90; Chirocaine SPC; AAGBI LAST Guidelines 2023. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
Pathways
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH